Fergal Hill

Oprichter bij Osivax SAS

Health Technology

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Alexandre Le Vert	M	-	Osivax SAS Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.	7 jaar
Florence Nicolas	M	-	Osivax SAS Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.	7 jaar
Christopher Martin	M	65	Osivax SAS Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.	1 jaar
Christian Pradeyrol	M	-	Osivax SAS Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.	-
Alexandre Heraud	M	-	Osivax SAS Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.	6 jaar
Michael Watson	M	-	Osivax SAS Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.	2 jaar
Thomas Joudinaud	M	-	Osivax SAS Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.	-
Hugues Wallemacq	M	-	Osivax SAS Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.	-